Announcements Trials

Browse Landscape

Phase

Status

Completed 71 Active not recruiting 62 Recruiting 49 Terminated 28 Unknown 25 Withdrawn 19 Not yet recruiting 8 Suspended 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

Pemetrexed 2 trilaciclib 1 trastuzumab deruxtecan 1 pembrolizumab 1 olaparib 1 lorlatinib 1 durvalumab 1 aumolertinib 1 apatinib 1 Standard of Care 1 Saline Solution 1 Radiosurgery 1 Patient Navigation 1 Observation 1 Interviews as Topic 1 Gemcitabine 1 Drug Delivery Systems 1 Cisplatin 1 Carboplatin 1 Biopsy, Fine-Needle 1 Anterior Temporal Lobectomy 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × durvalumab × Thoracic × Clear all

NCT06419179 2025-05-20

GUIDANCE

University of Cologne

Phase 2 Enrolling by invitation

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡